ACTA2 Gene Moyamoya disease type 5 Genetic Test
Genetic testing is an important tool in diagnosing and understanding various diseases. One such test is the ACTA2 Gene Moyamoya disease type 5 Genetic Test offered by DNA Labs UAE.
Test Components and Price
The ACTA2 Gene Moyamoya disease type 5 Genetic Test is priced at 4400.0 AED. The test requires a blood sample for analysis.
Report Delivery and Method
The test results are typically delivered within 3 to 4 weeks. The test utilizes NGS (Next-Generation Sequencing) technology to analyze the ACTA2 gene.
Test Type and Doctor
The ACTA2 Gene Moyamoya disease type 5 Genetic Test falls under the category of Cardiovascular Pneumology Disorders. It is performed by a Cardiologist in the Genetics department of DNA Labs UAE.
Pre Test Information
Prior to undergoing the ACTA2 Gene Moyamoya disease type 5 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session is conducted to draw a pedigree chart of family members affected by the disease.
Test Details
The ACTA2 gene is associated with Moyamoya disease type 5, a rare cerebrovascular disorder affecting the blood vessels in the brain. This disease is characterized by the narrowing and blockage of the internal carotid arteries, leading to reduced blood flow and increased risk of stroke.
NGS genetic testing allows for the simultaneous analysis of multiple genes, including the ACTA2 gene. This type of testing can identify specific genetic variations or mutations related to Moyamoya disease type 5. By analyzing the DNA sequence of the ACTA2 gene, NGS genetic testing aids in the diagnosis and provides information about the specific genetic cause of the condition.
Understanding the underlying mechanisms of Moyamoya disease type 5 is crucial for predicting disease progression and making informed treatment decisions. However, it is important to note that genetic testing for this disease is typically conducted in specialized genetic testing laboratories and requires a healthcare provider’s order.
Furthermore, it is essential to interpret genetic testing results in conjunction with the patient’s medical history, clinical symptoms, and other diagnostic tests to ensure accurate diagnosis and appropriate management.
| Test Name | ACTA2 Gene Moyamoya disease type 5 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cardiovascular Pneumology Disorders |
| Doctor | Cardiologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for ACTA2 Gene Moyamoya disease type 5 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ACTA2 Gene Moyamoya disease type 5 NGS Genetic DNA Test gene ACTA2 |
| Test Details |
The ACTA2 gene is associated with Moyamoya disease type 5. Moyamoya disease is a rare, progressive cerebrovascular disorder that affects the blood vessels in the brain. It is characterized by the narrowing and eventual blockage of the internal carotid arteries, leading to reduced blood flow and increased risk of stroke. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes, including the ACTA2 gene. This type of testing can identify specific genetic variations or mutations that may be associated with Moyamoya disease type 5. By analyzing the DNA sequence of the ACTA2 gene, NGS genetic testing can help diagnose Moyamoya disease type 5 and provide information about the specific genetic cause of the condition. This information can be useful for understanding the underlying mechanisms of the disease, predicting disease progression, and informing treatment decisions. It’s important to note that genetic testing for Moyamoya disease type 5 is typically performed in specialized genetic testing laboratories and requires a healthcare provider’s order. Additionally, genetic testing results should always be interpreted in conjunction with a person’s medical history, clinical symptoms, and other diagnostic tests to ensure accurate diagnosis and appropriate management. |
